HIV prevention research: taking stock and the way forward

被引:27
作者
Hayes, Richard [1 ]
Kapiga, Saidi [2 ,3 ]
Padian, Nancy [4 ]
McCormack, Sheena [5 ]
Wasserheit, Judith [6 ,7 ,8 ]
机构
[1] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1E 7HT, England
[2] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England
[3] Mwanza Intervent Trials Unit, Mwanza, Tanzania
[4] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA USA
[5] MRC Clin Trials Unit, London, England
[6] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[7] Univ Washington, Dept Med, Seattle, WA USA
[8] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
基金
英国医学研究理事会;
关键词
HIV; prevention and control; randomized controlled trials; sub-Saharan Africa; MALE CIRCUMCISION; VIRAL LOAD; TRANSMISSION; TREAT; RAKAI; MEN;
D O I
10.1097/01.aids.0000390710.04255.2b
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous papers in this supplement have reviewed the evidence of the effectiveness of alternative HIV prevention methods from randomized controlled trials and other studies This paper draws together the main conclusions from these reviews A conceptual framework is presented that maps the proximal and distal determinants of sexual HIV transmission and helps to identify the stages in the causal pathway at which each intervention approach acts The advances, gaps and challenges emerging from the reviews of individual intervention methods are summarized and cross-cutting themes identified Approximately 90% of HIV prevention trials have found no effect on HIV incidence and we explore the alternative explanations for the large number of 'flat' trials We conclude that there is no single explanation for these flat results, which may be due to interventions that are ineffective or inappropriately targeted or implemented, or to factors related to the design or conduct of trials We examine the lessons from these flat results and provide recommendations on what should be done differently in future trials HIV prevention remains of critical importance in an era of expanded delivery of antiretroviral therapy In future HIV prevention research, it is important that resources are used as efficiently as possible to provide rigorous evidence of the effectiveness of a wider array of complementary prevention tools (c) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:S81 / S92
页数:12
相关论文
共 24 条
[21]   Behavioural interventions to reduce HIV risk: what works? [J].
Ross, David A. .
AIDS, 2010, 24 :S4-S14
[22]   Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers:: a randomised controlled trial [J].
Van Damme, L ;
Ramjee, G ;
Alary, M ;
Vuylsteke, B ;
Chandeying, V ;
Rees, H ;
Sirivongrangson, P ;
Mukenge-Tshibaka, L ;
Ettiègne-Traoré, V ;
Uaheowitchai, C ;
Karim, SSA ;
Mâsse, B ;
Perriëns, J ;
Laga, M .
LANCET, 2002, 360 (9338) :971-977
[23]   Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission [J].
Weber, Jonathan ;
Tatoud, Roger ;
Fidler, Sarah .
AIDS, 2010, 24 :S27-S39
[24]   Male circumcision for HIV prevention: current research and programmatic issues [J].
Weiss, Helen A. ;
Dickson, Kim E. ;
Agot, Kawango ;
Hankins, Catherine A. .
AIDS, 2010, 24 :S61-S69